Our promise to you:
Guaranteed product quality, expert customer support.
24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
Creative Biogene presents to clients how successful applications in antibody production development translate into AAV to meet the challenges of scaling up their production.
Adeno-associated virus (AAV) has become a popular viral tool for research and clinical applications.
Adeno-associated virus (AAV) belongs to the family of parvoviridae, the viral particles have no envelope, and the structure is an ortho icosahedron with a diameter of about 20 nm.
Cardiovascular disease is a major cause of mortality affecting human beings. In recent years, gene therapy has emerged as a promising approach for treating and curing damaged cardiovascular tissues, capable of restoring the heart from a nonfunctional state to a normal state.
Adenovirus was originally used as a vector for gene therapy. In recent years, with the development of the next-generation vectors with increased safety and high immunogenicity to transgene products, its utility as a vaccine vector has continued to increase.
Copyright © 2026 Creative Biogene. All rights reserved.